Mapping Draining Lymph Nodes in CNS Malignancies

Status Terminated

Clinical Trial Summary

The purpose of this research study is to determine whether the lymph nodes that drain a brain tumor can be detected by imaging after injection of a substance called Tc-99m tilmanocept directly into the brain tissue around the tumor. Tc-99m tilmanocept is a radioactive substance that is used to find lymph nodes by injecting it and then scanning the body with a device that can trace its radioactivity. In this study, the investigators are looking to see how long it takes the Tc-99m tilmanocept to travel from the tumor to the lymph nodes. The investigators will be using it to map lymph nodes as they relate to specific brain areas.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04096716
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Terminated
Phase	Phase 1
Start date	December 3, 2019
Completion date	April 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04743310` - Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System	Phase 2
Completed	`NCT02496520` - Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults	Phase 1/Phase 2
Completed	`NCT00002594` - Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors	Phase 2
Active, not recruiting	`NCT02932280` - Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment	Phase 1/Phase 2
Completed	`NCT00078988` - High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas	Phase 3
Recruiting	`NCT06104488` - A Study of Avutometinib for People With Solid Tumor Cancers	Phase 1
Completed	`NCT00238264` - Radiation Therapy in Treating Young Patients With Gliomas	Phase 2
Completed	`NCT00006024` - Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma	Phase 1
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Completed	`NCT03981016` - Medical and Surgical Management of Patients With Brain Metastases	N/A
Recruiting	`NCT06054295` - Somatic Mosaicism in Twins Discordant for Childhood Cancer
Completed	`NCT00716976` - Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy	Phase 3
Recruiting	`NCT05978557` - Brain Slice Explants to Predict Drug Response in Brain Tumors
Recruiting	`NCT04852354` - Tissue Collection for Drug Screening and Bioanalysis
Completed	`NCT00077207` - Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma	N/A
Completed	`NCT00085098` - Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor	Phase 3
Active, not recruiting	`NCT03052738` - Medical Marijuana in the Pediatric Central Nervous System Tumor Population
Recruiting	`NCT03452774` - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting	`NCT01595126` - Longitudinal Study of Biomarkers	N/A
Recruiting	`NCT04185038` - Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors	Phase 1